These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21872953)

  • 41. Dosimetric effects of the acuros XB and anisotropic analytical algorithm on volumetric modulated arc therapy planning for prostate cancer using an endorectal balloon.
    Koo T; Chung JB; Eom KY; Seok JY; Kim IA; Kim JS
    Radiat Oncol; 2015 Feb; 10():48. PubMed ID: 25890071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Image-guided radiotherapy using surgical clips as fiducial markers after prostatectomy: a report of total setup error, required PTV expansion, and dosimetric implications.
    Song S; Yenice KM; Kopec M; Liauw SL
    Radiother Oncol; 2012 May; 103(2):270-4. PubMed ID: 21890224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies.
    Georg P; Georg D; Hillbrand M; Kirisits C; Pötter R
    Radiother Oncol; 2006 Jul; 80(1):19-26. PubMed ID: 16766068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ICRU reference dose in an era of intensity-modulated radiation therapy clinical trials: correlation with planning target volume mean dose and suitability for intensity-modulated radiation therapy dose prescription.
    Yaparpalvi R; Hong L; Mah D; Shen J; Mutyala S; Spierer M; Garg M; Guha C; Kalnicki S
    Radiother Oncol; 2008 Dec; 89(3):347-52. PubMed ID: 18762345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT.
    Vanetti E; Clivio A; Nicolini G; Fogliata A; Ghosh-Laskar S; Agarwal JP; Upreti RR; Budrukkar A; Murthy V; Deshpande DD; Shrivastava SK; Dinshaw KA; Cozzi L
    Radiother Oncol; 2009 Jul; 92(1):111-7. PubMed ID: 19157609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
    Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
    Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
    Das IJ; Cheng CW; Chopra KL; Mitra RK; Srivastava SP; Glatstein E
    J Natl Cancer Inst; 2008 Mar; 100(5):300-7. PubMed ID: 18314476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IMRT versus conventional 3DCRT on prostate and normal tissue dosimetry using an endorectal balloon for prostate immobilization.
    Vlachaki MT; Teslow TN; Amosson C; Uy NW; Ahmad S
    Med Dosim; 2005; 30(2):69-75. PubMed ID: 15922172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer.
    Peeters ST; Lebesque JV; Heemsbergen WD; van Putten WL; Slot A; Dielwart MF; Koper PC
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1151-61. PubMed ID: 16414208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
    Milby AB; Both S; Ingram M; Lin LL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e477-84. PubMed ID: 22177626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
    Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anal and rectal function after intensity-modulated prostate radiotherapy with endorectal balloon.
    Krol R; McColl GM; Hopman WPM; Smeenk RJ
    Radiother Oncol; 2018 Aug; 128(2):364-368. PubMed ID: 29716753
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An endorectal balloon reduces intrafraction prostate motion during radiotherapy.
    Smeenk RJ; Louwe RJ; Langen KM; Shah AP; Kupelian PA; van Lin EN; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):661-9. PubMed ID: 22099035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is an Endorectal Balloon Beneficial for Rectal Sparing after Spacer Implantation in Prostate Cancer Patients Treated with Hypofractionated Intensity-Modulated Proton Beam Therapy? A Dosimetric and Radiobiological Comparison Study.
    Ahmad Khalil D; Wulff J; Jazmati D; Geismar D; Bäumer C; Kramer PH; Steinmeier T; Schleithoff SS; Tschirdewahn S; Hadaschik B; Timmermann B
    Curr Oncol; 2023 Jan; 30(1):758-768. PubMed ID: 36661707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differences in radiation dosimetry and anorectal function testing imply that anorectal symptoms may arise from different anatomic substrates.
    Smeenk RJ; Hopman WP; Hoffmann AL; van Lin EN; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):145-52. PubMed ID: 20950951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adverse effect of a distended rectum in intensity-modulated radiotherapy (IMRT) treatment planning of prostate cancer.
    Guckenberger M; Pohl F; Baier K; Meyer J; Vordermark D; Flentje M
    Radiother Oncol; 2006 Apr; 79(1):59-64. PubMed ID: 16584794
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endorectal balloons in the post prostatectomy setting: do gains in stability lead to more predictable dosimetry?
    Jameson MG; De Leon J; Windsor AA; Cloak K; Keats S; Dowling JA; Chandra SS; Vial P; Sidhom M; Holloway L; Metcalfe P
    Radiother Oncol; 2013 Dec; 109(3):493-7. PubMed ID: 24044793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of the use of an endorectal balloon on rectal dosimetry during stereotactic body radiation therapy for localized prostate cancer.
    Wong AT; Schreiber D; Agarwal M; Polubarov A; Schwartz D
    Pract Radiat Oncol; 2016; 6(4):262-267. PubMed ID: 26725959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patterns in ano-rectal dose maps and the risk of late toxicity after prostate IMRT.
    Onjukka E; Fiorino C; Cicchetti A; Palorini F; Improta I; Gagliardi G; Cozzarini C; Degli Esposti C; Gabriele P; Valdagni R; Rancati T
    Acta Oncol; 2019 Dec; 58(12):1757-1764. PubMed ID: 31298076
    [No Abstract]   [Full Text] [Related]  

  • 60. Endorectal balloon (ERB) in helical tomotherapy (HT) for localized prostate cancer: a case report of dosimetric analysis.
    Yeo SG; Cho KH
    Transl Cancer Res; 2021 Sep; 10(9):4250-4255. PubMed ID: 35116721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.